ArticleUrologic oncology2022

Influence of first-line chemotherapy regimen on survival outcomes of patients with advanced urothelial carcinoma who received second-line immune checkpoint inhibitors.

Benjamin Miron et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.